These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8443393)

  • 1. Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts.
    Uckun FM; Song CW
    Blood; 1993 Mar; 81(5):1323-32. PubMed ID: 8443393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation resistance of primary clonogenic blasts from children with acute lymphoblastic leukemia.
    Uckun FM; Aeppli D; Song CW
    Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):899-906. PubMed ID: 8244821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia.
    Uckun FM; Jaszcz W; Chandan-Langlie M; Waddick KG; Gajl-Peczalska K; Song CW
    J Clin Invest; 1993 Mar; 91(3):1044-51. PubMed ID: 8450034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia.
    Uckun FM; Ramsay NK; Waddick KG; Jaszcz W; Chandan-Langlie M; Obuz V; Haake R; Gajl-Peczalska K; Kersey JH; Song CW
    Blood; 1991 Dec; 78(11):2945-55. PubMed ID: 1835411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotype predicts radiation resistance in T-lineage acute lymphoblastic leukemia and T-lineage non-Hodgkin's lymphoma.
    Uckun FM; Song CW; Nesbit M; Kersey JH; Ramsay NK
    Int J Radiat Oncol Biol Phys; 1992; 24(4):705-12. PubMed ID: 1429095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation damage repair capacity of primary clonogenic blasts in acute lymphoblastic leukemia.
    Uckun FM; Chandan-Langlie M; Jaszcz W; Obuz V; Waddick K; Song CW
    Cancer Res; 1993 Mar; 53(6):1431-6. PubMed ID: 8443821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engagement of the CD19 receptor on human B-lineage leukemia cells activates LCK tyrosine kinase and facilitates radiation-induced apoptosis.
    Waddick KG; Chae HP; Tuel-Ahlgren L; Jarvis LJ; Dibirdik I; Myers DE; Uckun FM
    Radiat Res; 1993 Dec; 136(3):313-9. PubMed ID: 7506428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
    Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
    Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
    Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamide.
    Uckun FM; Chandan-Langlie M; Dockham PA; Aeppli D; Sladek NE
    Leuk Lymphoma; 1994 May; 13(5-6):417-28. PubMed ID: 8069187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting.
    Mikhailova E; Itov A; Zerkalenkova E; Roumiantseva J; Olshanskaya Y; Karachunskiy A; Novichkova G; Maschan M; Popov A
    Cytometry B Clin Cytom; 2022 Sep; 102(5):353-359. PubMed ID: 35796438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema).
    De Rossi G; Grossi C; Foà R; Tabilio A; Vègna L; Lo Coco F; Annino L; Camera A; Cascavilla N; Ciolli S
    Leuk Lymphoma; 1993 Feb; 9(3):221-8. PubMed ID: 8471981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells.
    Uckun FM; Gajl-Peczalska K; Myers DE; Jaszcz W; Haissig S; Ledbetter JA
    Blood; 1990 Dec; 76(12):2449-56. PubMed ID: 1702326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human granulocyte-macrophage colony-stimulating factor supports the clonogenic growth of B-lineage acute lymphoblastic leukemias expressing myeloid antigens.
    Gattei V; Aldinucci D; Attadia V; Degan M; Alosi MS; De Iuliis A; Babare R; Rossi FM; Rupolo M; Zagonel V; Pinto A
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):141-51. PubMed ID: 9426972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of functional CD40 in B-lineage acute lymphoblastic leukemia cells in response to T-cell CD40 ligand.
    Renard N; Lafage-Pochitaloff M; Durand I; Duvert V; Coignet L; Banchereau J; Saeland S
    Blood; 1996 Jun; 87(12):5162-70. PubMed ID: 8652829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.
    Uckun FM; Muraguchi A; Ledbetter JA; Kishimoto T; O'Brien RT; Roloff JS; Gajl-Peczalska K; Provisor A; Koller B
    Blood; 1989 Mar; 73(4):1000-15. PubMed ID: 2784064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challenges.
    Chatterjee G; Dhende P; Raj S; Shetty V; Ghogale S; Deshpande N; Girase K; Patil J; Kalra A; Narula G; Dalvi K; Dhamne C; Moulik NR; Rajpal S; Patkar NV; Banavali S; Gujral S; Subramanian PG; Tembhare PR
    Eur J Haematol; 2024 Jan; 112(1):122-136. PubMed ID: 37706583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
    Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
    Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiological features of fresh leukemic bone marrow progenitor cells in acute lymphoblastic leukemia.
    Uckun FM; Song CW
    Cancer Res; 1988 Oct; 48(20):5788-95. PubMed ID: 3262412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.